Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Titel:
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
Auteur:
Swiha, Mina M. Sutherland, Duncan E. K. Sistani, Golmehr Khatami, Alireza Abazid, Rami M. Mujoomdar, Amol Wiseman, Daniele P. Romsa, Jonathan G. Reid, Robert H. Laidley, David T.